US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Envoy Medical Inc.

0.4701

-0.0014-0.30%

Post-market: 0.4692-0.0009-0.19%18:50 EST

Volume:197.81K

Turnover:93.10K

Market Cap:13.53M

PE:-0.34

High:0.4800

Open:0.4800

Low:0.4585

Close:0.4715

52wk High:1.91

52wk Low:0.4300

Shares:28.79M

Float Shares:18.01M

Volume Ratio:0.72

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3638

EPS(LYR):-1.4887

ROE:--

ROA:-145.31%

PB:-1.80

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Envoy Medical to Present at Small Cap Growth Virtual Investor Conference

Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial

Envoy Medical Secures Australian Patent for Fully Implanted Cochlear Implant Innovation

Envoy Medical Activates First Patients in Pivotal Trial of Fully Implanted Acclaim Cochlear Implant

Envoy Medical Inc. Held Special Meeting of Stockholders

Envoy Medical Inc. Granted 40th U.S. Patent for Fully Implanted Hearing Device Technology

Envoy Medical Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

Envoy Medical Granted U.S. Patent for Innovative Cochlear Implant System with Removable Earplug Sensor and Implanted Battery

Envoy Medical Reports Six-Month Success in Acclaim Cochlear Implant Trial

Envoy Medical Q3 EPS $(0.35) Misses $(0.28) Estimate, Sales $42.000K Miss $70.000K Estimate

Envoy Medical Eliminates $32 Million Debt and Advances Clinical Trial After FDA Approval

Dow Jumps Over 100 Points; US Crude Oil Inventories Increase

Nasdaq Gains 150 Points; US Mortgage Applications Decline

Envoy Medical Signs Deals for Sale of Common Shares, Warrants

MT Newswires Live

Envoy Medical Announces $16 Million Registered Direct and Private Placement Offering, Including $4 Million Upfront and Warrants for Potential $12 Million Additional Proceeds

Envoy Medical Inc. Announces Date for Upcoming Special Meeting of Stockholders

BRIEF-Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage

Envoy Medical: Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

THOMSON REUTERS

Envoy Medical Inc -Moving Its Timelines up Three to Six Months, Cutting Its Anticipated Capital Need by $10-$15 Million

THOMSON REUTERS

Envoy Medical Inc - Expects Full Enrollment by Early 2026 - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/COCH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"COCH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCH\",,,,,undefined,":{"symbol":"COCH","market":"US","secType":"STK","nameCN":"Envoy Medical Inc.","latestPrice":0.4701,"timestamp":1770670800000,"preClose":0.4715,"halted":0,"volume":197808,"hourTrading":{"tag":"盘后","latestPrice":0.4692,"preClose":0.4701,"latestTime":"18:50 EST","volume":1365,"amount":638.6198,"timestamp":1770681059190,"change":-0.0009,"changeRate":-0.001914,"amplitude":0.021485},"delay":0,"changeRate":-0.002969247083775094,"floatShares":18008500,"shares":28786511,"eps":-1.363837,"marketStatus":"Not Yet Opened","change":-0.0014,"latestTime":"02-09 16:00:00 EST","open":0.48,"high":0.48,"low":0.4585,"amount":93104.98748304001,"amplitude":0.045599,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.363837,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4715,"preHourTrading":{"tag":"盘前","latestPrice":0.461,"preClose":0.4715,"latestTime":"09:19 EST","volume":5375,"amount":2479.01519875,"timestamp":1770646794125,"change":-0.0105,"changeRate":-0.022269,"amplitude":0.012725},"postHourTrading":{"tag":"盘后","latestPrice":0.4692,"preClose":0.4701,"latestTime":"18:50 EST","volume":1365,"amount":638.6198,"timestamp":1770681059190,"change":-0.0009,"changeRate":-0.001914,"amplitude":0.021485},"volumeRatio":0.720406},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCH\",,,,,undefined,":{"symbol":"COCH","floatShares":18008500,"roa":"-145.31%","roe":"--","lyrEps":-1.488681,"volumeRatio":0.720406,"shares":28786511,"dividePrice":0,"high":0.48,"amplitude":0.045599,"preClose":0.4715,"low":0.4585,"week52Low":0.43,"pbRate":"-1.80","psRate":"65.06","week52High":1.91,"institutionHeld":0,"latestPrice":0.4701,"eps":-1.363837,"divideRate":0,"volume":197808,"delay":0,"ttmEps":-1.363837,"open":0.48,"prevYearClose":0.6611,"prevWeekClose":0.4715,"prevMonthClose":0.6499,"prevQuarterClose":0.6611,"fiveDayClose":0.6499,"twentyDayClose":0.6796,"sixtyDayClose":0.7018},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COCH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"COCH","fiscalQuarterEnding":"2025/09","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2025-07-31","symbol":"COCH","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COCH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COCH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COCH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COCH","date":"2026-02-06","current":-0.344689,"percent":0.932358,"low":-5.350942,"twenty":-2.383454,"median":-1.496567,"eighty":-0.949434,"high":-0.457484,"avg":-1.846505,"sd":1.122753,"marketCap":15256850},"quantilePoints":[{"date":"2023-10-20","current":-0.862855,"twenty":-0.980129,"median":-0.936152,"eighty":-0.892174,"marketCap":33923128},{"date":"2023-10-27","current":-0.56191,"twenty":-0.921492,"median":-0.846644,"eighty":-0.723024,"marketCap":22091479},{"date":"2023-11-03","current":-0.606664,"twenty":-0.843402,"median":-0.621582,"eighty":-0.602686,"marketCap":23850978},{"date":"2023-11-10","current":-0.472402,"twenty":-0.749876,"median":-0.601691,"eighty":-0.51815,"marketCap":18572482},{"date":"2023-11-17","current":-0.472402,"twenty":-0.651418,"median":-0.522128,"eighty":-0.472998,"marketCap":18572482},{"date":"2023-11-24","current":-0.658735,"twenty":-0.643874,"median":-0.522128,"eighty":-0.478269,"marketCap":24046477},{"date":"2023-12-01","current":-1.205004,"twenty":-0.79603,"median":-0.579314,"eighty":-0.486255,"marketCap":43987459},{"date":"2023-12-08","current":-1.065759,"twenty":-0.982212,"median":-0.606688,"eighty":-0.487287,"marketCap":38904464},{"date":"2023-12-15","current":-1.183582,"twenty":-1.025567,"median":-0.614147,"eighty":-0.487322,"marketCap":43205460},{"date":"2023-12-22","current":-1.205004,"twenty":-1.125741,"median":-0.658735,"eighty":-0.492322,"marketCap":43987459},{"date":"2023-12-29","current":-0.98007,"twenty":-1.149306,"median":-0.677453,"eighty":-0.507218,"marketCap":35776467},{"date":"2024-01-05","current":-1.017559,"twenty":-1.132168,"median":-0.744425,"eighty":-0.515106,"marketCap":37144965},{"date":"2024-01-12","current":-0.685513,"twenty":-1.097893,"median":-0.784591,"eighty":-0.520546,"marketCap":25023976},{"date":"2024-01-19","current":-0.760491,"twenty":-1.062556,"median":-0.763169,"eighty":-0.522128,"marketCap":27760974},{"date":"2024-01-26","current":-0.70158,"twenty":-1.043309,"median":-0.744425,"eighty":-0.524814,"marketCap":25610476},{"date":"2024-02-02","current":-0.642669,"twenty":-1.016488,"median":-0.72568,"eighty":-0.540828,"marketCap":23459978},{"date":"2024-02-09","current":-0.734999,"twenty":-1.011652,"median":-0.728358,"eighty":-0.568872,"marketCap":26830395},{"date":"2024-02-16","current":-0.669447,"twenty":-1.005715,"median":-0.723002,"eighty":-0.598707,"marketCap":24437477},{"date":"2024-02-23","current":-0.648024,"twenty":-0.990781,"median":-0.722172,"eighty":-0.606664,"marketCap":23655478},{"date":"2024-03-01","current":-2.522475,"twenty":-1.009448,"median":-0.721342,"eighty":-0.606713,"marketCap":92080415},{"date":"2024-03-08","current":-4.118435,"twenty":-1.065759,"median":-0.723002,"eighty":-0.610535,"marketCap":150339361},{"date":"2024-03-15","current":-2.20114,"twenty":-1.205004,"median":-0.733713,"eighty":-0.621246,"marketCap":80350426},{"date":"2024-03-22","current":-2.072607,"twenty":-1.242493,"median":-0.741747,"eighty":-0.621582,"marketCap":75658430},{"date":"2024-03-28","current":-2.094029,"twenty":-1.895873,"median":-0.755135,"eighty":-0.638452,"marketCap":76440429},{"date":"2024-04-05","current":-3.138365,"twenty":-2.0951,"median":-0.771202,"eighty":-0.642669,"marketCap":114562894},{"date":"2024-04-12","current":-3.984482,"twenty":-2.188287,"median":-0.821545,"eighty":-0.646953,"marketCap":119167890},{"date":"2024-04-19","current":-3.3488,"twenty":-2.453924,"median":-0.835469,"eighty":-0.656593,"marketCap":100155908},{"date":"2024-04-26","current":-3.316033,"twenty":-3.138365,"median":-0.926514,"eighty":-0.658735,"marketCap":99175908},{"date":"2024-05-03","current":-3.178411,"twenty":-3.186275,"median":-0.98007,"eighty":-0.66302,"marketCap":95059912},{"date":"2024-05-10","current":-2.195397,"twenty":-3.146374,"median":-1.010825,"eighty":-0.668376,"marketCap":65659939},{"date":"2024-05-17","current":-2.581982,"twenty":-3.138365,"median":-1.049746,"eighty":-0.669447,"marketCap":59191945},{"date":"2024-05-24","current":-2.607631,"twenty":-2.975556,"median":-1.130026,"eighty":-0.673731,"marketCap":59779945},{"date":"2024-05-31","current":-2.056181,"twenty":-2.915842,"median":-1.194293,"eighty":-0.674802,"marketCap":47137956},{"date":"2024-06-07","current":-1.812517,"twenty":-2.871711,"median":-1.205004,"eighty":-0.681229,"marketCap":41551961},{"date":"2024-06-14","current":-2.299845,"twenty":-2.824526,"median":-1.242493,"eighty":-0.686713,"marketCap":52723951},{"date":"2024-06-21","current":-2.051906,"twenty":-2.782179,"median":-1.478138,"eighty":-0.688983,"marketCap":47039956},{"date":"2024-06-28","current":-1.957861,"twenty":-2.776126,"median":-1.786869,"eighty":-0.689926,"marketCap":44883958},{"date":"2024-07-05","current":-2.000609,"twenty":-2.733159,"median":-1.879806,"eighty":-0.69299,"marketCap":45863957},{"date":"2024-07-12","current":-1.97496,"twenty":-2.670243,"median":-1.932212,"eighty":-0.696192,"marketCap":45275958},{"date":"2024-07-15","current":-2.043357,"twenty":-2.666472,"median":-1.940762,"eighty":-0.696203,"marketCap":46843956},{"date":"2024-08-02","current":-1.96641,"twenty":-2.6627,"median":-1.949312,"eighty":-0.696213,"marketCap":45079958},{"date":"2024-08-09","current":-2.051906,"twenty":-2.617891,"median":-1.957861,"eighty":-0.696224,"marketCap":47039956},{"date":"2024-08-16","current":-3.750569,"twenty":-2.7731,"median":-1.963275,"eighty":-0.696224,"marketCap":50763953},{"date":"2024-08-23","current":-3.970054,"twenty":-2.975556,"median":-1.981562,"eighty":-0.700509,"marketCap":54095950},{"date":"2024-08-30","current":-4.300891,"twenty":-3.226906,"median":-1.99215,"eighty":-0.70158,"marketCap":58603946},{"date":"2024-09-06","current":-4.473502,"twenty":-3.312101,"median":-2.000609,"eighty":-0.70158,"marketCap":60955944},{"date":"2024-09-13","current":-4.811532,"twenty":-3.364528,"median":-2.000609,"eighty":-0.713437,"marketCap":65561939},{"date":"2024-09-20","current":-4.588576,"twenty":-3.74188,"median":-2.021983,"eighty":-0.722338,"marketCap":62523942},{"date":"2024-09-27","current":-4.876261,"twenty":-3.933938,"median":-2.034807,"eighty":-0.723002,"marketCap":66443938},{"date":"2024-10-04","current":-4.373081,"twenty":-3.989387,"median":-2.051906,"eighty":-0.723002,"marketCap":59587595},{"date":"2024-10-11","current":-4.054512,"twenty":-4.031318,"median":-2.056181,"eighty":-0.726216,"marketCap":55246777},{"date":"2024-10-18","current":-3.953149,"twenty":-4.021044,"median":-2.075081,"eighty":-0.731571,"marketCap":53865608},{"date":"2024-10-25","current":-3.63458,"twenty":-4.013314,"median":-2.094029,"eighty":-0.734485,"marketCap":49524789},{"date":"2024-10-31","current":-3.576659,"twenty":-4.006171,"median":-2.103204,"eighty":-0.736627,"marketCap":48735550},{"date":"2024-11-08","current":-2.954001,"twenty":-3.997991,"median":-2.152012,"eighty":-0.741211,"marketCap":40251223},{"date":"2024-11-15","current":-3.084325,"twenty":-3.99184,"median":-2.169007,"eighty":-0.746567,"marketCap":42027012},{"date":"2024-11-22","current":-2.115049,"twenty":-3.983533,"median":-2.152012,"eighty":-0.754064,"marketCap":44538703},{"date":"2024-11-29","current":-2.19196,"twenty":-3.981274,"median":-2.137093,"eighty":-0.761562,"marketCap":46158292},{"date":"2024-12-06","current":-2.076594,"twenty":-3.976354,"median":-2.124663,"eighty":-0.766918,"marketCap":43728908},{"date":"2024-12-13","current":-1.999683,"twenty":-3.966673,"median":-2.115049,"eighty":-0.771738,"marketCap":42109319},{"date":"2024-12-20","current":-1.76895,"twenty":-3.953149,"median":-2.103204,"eighty":-0.78277,"marketCap":37250551},{"date":"2024-12-27","current":-1.653584,"twenty":-3.953149,"median":-2.095821,"eighty":-0.818331,"marketCap":34821167},{"date":"2025-01-03","current":-1.480534,"twenty":-3.941565,"median":-2.090542,"eighty":-0.823473,"marketCap":31177092},{"date":"2025-01-10","current":-1.442079,"twenty":-3.921384,"median":-2.076594,"eighty":-0.828163,"marketCap":30367297},{"date":"2025-01-17","current":-1.442079,"twenty":-3.903517,"median":-2.069794,"eighty":-0.833455,"marketCap":30367297},{"date":"2025-01-24","current":-1.490148,"twenty":-3.88608,"median":-2.06698,"eighty":-0.846423,"marketCap":31379540},{"date":"2025-01-31","current":-1.567155,"twenty":-3.855998,"median":-2.057366,"eighty":-0.87975,"marketCap":33001154},{"date":"2025-02-07","current":-1.499762,"twenty":-3.806073,"median":-2.054043,"eighty":-0.92223,"marketCap":31581989},{"date":"2025-02-14","current":-1.39401,"twenty":-3.752802,"median":-2.051906,"eighty":-0.95222,"marketCap":29355054},{"date":"2025-02-21","current":-1.465152,"twenty":-3.747673,"median":-2.034807,"eighty":-0.962932,"marketCap":30853174},{"date":"2025-02-28","current":-1.269029,"twenty":-3.736059,"median":-2.022584,"eighty":-0.982212,"marketCap":26723221},{"date":"2025-03-07","current":-1.314662,"twenty":-3.733047,"median":-2.009158,"eighty":-0.994514,"marketCap":27684148},{"date":"2025-03-14","current":-1.466241,"twenty":-3.715671,"median":-2.000609,"eighty":-1.009999,"marketCap":30876098},{"date":"2025-03-21","current":-1.446017,"twenty":-3.689606,"median":-1.999683,"eighty":-1.013274,"marketCap":30450221},{"date":"2025-03-28","current":-1.400513,"twenty":-3.672229,"median":-1.987785,"eighty":-1.023996,"marketCap":29491997},{"date":"2025-04-04","current":-1.413105,"twenty":-3.646165,"median":-1.97496,"eighty":-1.052949,"marketCap":29385528},{"date":"2025-04-11","current":-1.292212,"twenty":-3.632473,"median":-1.960684,"eighty":-1.07647,"marketCap":26871539},{"date":"2025-04-17","current":-1.353745,"twenty":-3.624044,"median":-1.957861,"eighty":-1.119315,"marketCap":28151137},{"date":"2025-04-25","current":-1.497325,"twenty":-3.576659,"median":-1.932212,"eighty":-1.140737,"marketCap":31136863},{"date":"2025-05-02","current":-1.415279,"twenty":-3.547698,"median":-1.895465,"eighty":-1.183582,"marketCap":29430734},{"date":"2025-05-09","current":-1.660424,"twenty":-3.533217,"median":-1.879806,"eighty":-1.205004,"marketCap":32416460},{"date":"2025-05-16","current":-1.813358,"twenty":-3.402894,"median":-1.836381,"eighty":-1.205004,"marketCap":35402187},{"date":"2025-05-23","current":-1.818819,"twenty":-3.394674,"median":-1.835205,"eighty":-1.205004,"marketCap":35508803},{"date":"2025-05-30","current":-1.747814,"twenty":-3.389431,"median":-1.825702,"eighty":-1.219999,"marketCap":34122574},{"date":"2025-06-06","current":-1.518413,"twenty":-3.356664,"median":-1.812937,"eighty":-1.238744,"marketCap":29643986},{"date":"2025-06-13","current":-1.573033,"twenty":-3.347546,"median":-1.780586,"eighty":-1.263722,"marketCap":30710316},{"date":"2025-06-20","current":-1.529337,"twenty":-3.328513,"median":-1.769663,"eighty":-1.282939,"marketCap":29857252},{"date":"2025-06-27","current":-1.616728,"twenty":-3.316033,"median":-1.747814,"eighty":-1.298365,"marketCap":31563381},{"date":"2025-07-03","current":-1.715043,"twenty":-3.313411,"median":-1.723235,"eighty":-1.304149,"marketCap":33482776},{"date":"2025-07-11","current":-1.573033,"twenty":-3.306858,"median":-1.704119,"eighty":-1.309092,"marketCap":30710316},{"date":"2025-07-18","current":-1.857052,"twenty":-3.287198,"median":-1.709581,"eighty":-1.313499,"marketCap":36255235},{"date":"2025-07-25","current":-1.780586,"twenty":-3.245255,"median":-1.731428,"eighty":-1.315637,"marketCap":34762372},{"date":"2025-08-01","current":-1.59499,"twenty":-3.202003,"median":-1.709581,"eighty":-1.320129,"marketCap":31138981},{"date":"2025-08-08","current":-1.501054,"twenty":-3.162393,"median":-1.704119,"eighty":-1.324673,"marketCap":31921424},{"date":"2025-08-15","current":-1.477502,"twenty":-3.138365,"median":-1.693195,"eighty":-1.327278,"marketCap":31420560},{"date":"2025-08-22","current":-1.194146,"twenty":-3.128333,"median":-1.671347,"eighty":-1.320129,"marketCap":25394699},{"date":"2025-08-29","current":-1.224505,"twenty":-3.101702,"median":-1.663591,"eighty":-1.304149,"marketCap":26040327},{"date":"2025-09-05","current":-1.366183,"twenty":-3.081429,"median":-1.660423,"eighty":-1.303066,"marketCap":29053258},{"date":"2025-09-12","current":-1.345944,"twenty":-3.066949,"median":-1.654962,"eighty":-1.296769,"marketCap":28622839},{"date":"2025-09-19","current":-1.386423,"twenty":-3.046676,"median":-1.647118,"eighty":-1.303066,"marketCap":29483676},{"date":"2025-09-26","current":-0.861202,"twenty":-3.000339,"median":-1.627652,"eighty":-1.286622,"marketCap":18314313},{"date":"2025-10-03","current":-0.845878,"twenty":-2.950172,"median":-1.616728,"eighty":-1.242943,"marketCap":17988436},{"date":"2025-10-10","current":-1.062637,"twenty":-2.928517,"median":-1.616728,"eighty":-1.223899,"marketCap":22598047},{"date":"2025-10-17","current":-0.951682,"twenty":-2.892682,"median":-1.595445,"eighty":-1.196318,"marketCap":20238478},{"date":"2025-10-24","current":-1.109127,"twenty":-2.848224,"median":-1.586287,"eighty":-1.167745,"marketCap":23586701},{"date":"2025-10-31","current":-1.009744,"twenty":-2.838158,"median":-1.578799,"eighty":-1.137564,"marketCap":21473218},{"date":"2025-11-07","current":-0.979268,"twenty":-2.827567,"median":-1.573033,"eighty":-1.09575,"marketCap":20825121},{"date":"2025-11-14","current":-0.874336,"twenty":-2.782179,"median":-1.55917,"eighty":-1.068311,"marketCap":19050025},{"date":"2025-11-21","current":-0.921147,"twenty":-2.751616,"median":-1.548341,"eighty":-1.04304,"marketCap":20069955},{"date":"2025-11-28","current":-1.108759,"twenty":-2.677786,"median":-1.547831,"eighty":-1.029836,"marketCap":24157640},{"date":"2025-12-05","current":-1.117347,"twenty":-2.658929,"median":-1.540058,"eighty":-1.041364,"marketCap":24344752},{"date":"2025-12-12","current":-1.100039,"twenty":-2.607631,"median":-1.529337,"eighty":-1.049746,"marketCap":23967649},{"date":"2025-12-19","current":-0.924847,"twenty":-2.607631,"median":-1.528971,"eighty":-1.028153,"marketCap":20150557},{"date":"2025-12-26","current":-0.990114,"twenty":-2.593952,"median":-1.522275,"eighty":-1.014932,"marketCap":21572611},{"date":"2026-01-02","current":-0.873452,"twenty":-2.585402,"median":-1.518124,"eighty":-1.009626,"marketCap":19030762},{"date":"2026-01-09","current":-0.912956,"twenty":-2.566593,"median":-1.509376,"eighty":-0.990834,"marketCap":19891479},{"date":"2026-01-16","current":-0.886796,"twenty":-2.536019,"median":-1.505215,"eighty":-0.983473,"marketCap":19321506},{"date":"2026-01-23","current":-0.88521,"twenty":-2.488199,"median":-1.499762,"eighty":-0.971998,"marketCap":19286962},{"date":"2026-01-30","current":-0.879661,"twenty":-2.42179,"median":-1.497742,"eighty":-0.956952,"marketCap":19166059},{"date":"2026-02-06","current":-0.700241,"twenty":-2.383454,"median":-1.496567,"eighty":-0.949434,"marketCap":15256850}],"updateTime":1770702160471},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COCH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607080710","title":"Envoy Medical to Present at Small Cap Growth Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2607080710","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607080710?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:35","pubTimestamp":1769693716,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026. The company’s management is scheduled to present at 10:00 A.M. ET, followed by a live question-and-answer session. A recording of the presentation will be made available on Envoy Medical’s Investor Relations website after the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on January 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL9pSxsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","IE00B64PRP62.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","LU2095319765.USD","BK4585","BK4112","LU2210150020.SGD","BK4588","SG9999014005.SGD","SG9999014021.USD","IE00BKPKM429.USD","BK4082","LU2210149790.SGD","NDAQ","SG9999014039.USD"],"gpt_icon":0},{"id":"2592906544","title":"Envoy Medical Hits Enrollment Milestone in Pivotal Acclaim Cochlear Implant Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906544","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906544?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:02","pubTimestamp":1766062963,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. announced that its pivotal clinical study for the investigational fully implanted Acclaim cochlear implant has reached the midway point of its full enrollment target. The company reports that enrollment is progressing steadily and remains on track for completion within the first half of the first quarter of 2026. The Acclaim cochlear implant is designed to utilize a proprietary implanted piezoelectric sensor to capture sound through the natural ear, rather than relying on an external microphone. Results from the pivotal study have not yet been presented and are expected to be available following the completion of enrollment and subsequent phases of the trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9fBMFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2591982826","title":"Envoy Medical Secures Australian Patent for Fully Implanted Cochlear Implant Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2591982826","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591982826?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:03","pubTimestamp":1765890239,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the issuance of Australian Patent No. 2022229818, granted by the Australian Patent Office on October 16, 2025. The new patent is aimed at enhancing the input signal-to-noise ratio in cochlear implant technology and further strengthens the company's global intellectual property portfolio. The company stated that it remains committed to establishing and protecting its competitive advantages within the hearing health industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on December 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL5vRK5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2590458207","title":"Envoy Medical Activates First Patients in Pivotal Trial of Fully Implanted Acclaim Cochlear Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2590458207","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590458207?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:01","pubTimestamp":1765371697,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the completion of the first set of activations in the final stage of its pivotal clinical study for the investigational fully implanted Acclaim cochlear implant. The activations took place at Shohet Ear Associates in Seal Beach, California, and the Center for Neurosciences Ear and Hearing Center in Tucson, Arizona, which are among the seven investigational sites involved in the study. No serious adverse events were reported during these initial activations. Specific hearing results from the clinical study have not yet been disclosed and will be presented after the trial is completed. Full enrollment for the pivotal trial is expected in early 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Med","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL1Dnkf8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2588021149","title":"Envoy Medical Inc. Held Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2588021149","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588021149?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:02","pubTimestamp":1764795726,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. held a Special Meeting of Stockholders on November 26, 2025. Stockholders approved the issuance of warrants to purchase shares of Class A Common Stock and the issuance of shares underlying those warrants, as outlined in a securities purchase agreement and an engagement letter with H.C. Wainwright & Co., LLC. Additionally, an administrative proposal allowing adjournment of the meeting, if necessary, was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 03, 2025, and is solely responsi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDLNhc0b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2588305328","title":"Envoy Medical Inc. Granted 40th U.S. Patent for Fully Implanted Hearing Device Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305328","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305328?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:03","pubTimestamp":1764680582,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced the grant of its 40th active U.S. patent, further strengthening its intellectual property portfolio. The company also holds 45 issued foreign patents. The newly granted U.S. Patent No. 12,485,288 covers proprietary cochlear implant systems designed to enhance performance and reliability, enabling real-time measurement and adjustment of electrical current delivered from the implant's stimulator to the auditory nerve.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on December 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL6LYhns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2586406038","title":"Envoy Medical Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406038","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586406038?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:02","pubTimestamp":1764104558,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has received a notice from the Nasdaq Stock Market indicating that its Class A Common Stock has failed to meet the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 calendar days, until May 18, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. If it does not meet this requirement, Envoy Medical may be eligible for an additional 180-day compliance period, provided it meets other listing standards and notifies Nasdaq of its plan to address the deficiency, potentially through a reverse stock split. If compliance is not achieved, the company could face delisting, though it would have the option to appeal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL9kGpdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2584748131","title":"Envoy Medical Granted U.S. Patent for Innovative Cochlear Implant System with Removable Earplug Sensor and Implanted Battery","url":"https://stock-news.laohu8.com/highlight/detail?id=2584748131","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584748131?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:01","pubTimestamp":1763643705,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. announced the issuance of U.S. Patent No. 12,465,754 for its innovative cochlear implant system featuring a removable earplug sensor and an implanted battery. The patent covers a combination implant system where an implantable subsystem, including a stimulator and rechargeable energy storage, works with a removable earplug equipped with a sensor and signal processor. This development expands the company's intellectual property portfolio and reinforces its position in next-generation cochlear implant technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on November 20, 2025, and is solely responsible for the informati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL3SG1Gg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2584372689","title":"Envoy Medical Reports Six-Month Success in Acclaim Cochlear Implant Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2584372689","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584372689?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:03","pubTimestamp":1763470993,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. announced that all 10 patients in the first stage of its pivotal clinical trial for the investigational Acclaim fully implanted cochlear implant have successfully completed their six-month follow-up visits. According to the company, no serious adverse events have been reported, supporting the device's safety profile. The Acclaim cochlear implant, which received Breakthrough Device Designation from the FDA in 2019, is currently being evaluated in a U.S.-based pivotal clinical trial. The trial has recently expanded, and results from the initial cohort have already been collected and reported as part of the six-month milestone. Further information about the ongoing trial is available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL5PPdD9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2582871374","title":"Envoy Medical Q3 EPS $(0.35) Misses $(0.28) Estimate, Sales $42.000K Miss $70.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871374","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871374?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:15","pubTimestamp":1762780528,"startTime":"0","endTime":"0","summary":"Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.28) by 25 percent. This is a 10.26 percent increase over losses of $(0.39) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48749710/envoy-medical-q3-eps-0-35-misses-0-28-estimate-sales-42-000k-miss-70-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2582871837","title":"Envoy Medical Eliminates $32 Million Debt and Advances Clinical Trial After FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871837","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871837?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:07","pubTimestamp":1762780054,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. reported its financial and operational results for the third quarter ended September 30, 2025. The company announced it extinguished over $32 million in debt during the quarter, strengthening its balance sheet without issuing new equity and materially improving stockholder's equity. Third quarter net revenue was $42,000. General and administrative expenses increased by $752,000 compared to the same period in 2024, primarily due to higher public company costs and expenses related to the September 2025 offering. As of September 30, 2025, Envoy Medical reported cash of approximately $3.6 million, with additional capital raised after the quarter ended. Operational highlights included the receipt of FDA approval to expand its pivotal clinical trial of the fully implanted investigational Acclaim cochlear implant to its final stage and the enrollment of the first three patients in this stage. The company also expanded its patent portfolio during the quarter.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL6BVsHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2574975532","title":"Dow Jumps Over 100 Points; US Crude Oil Inventories Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2574975532","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574975532?lang=en_us&edition=fundamental","pubTime":"2025-10-09 01:22","pubTimestamp":1759944170,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/10/48108006/dow-jumps-over-100-points-us-crude-oil-inventories-increase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TQQQ","DELL","TSYW.SI","BK4170","LU0976567544.SGD","USJW.SI","BK4535","LU0052756011.USD","BK4585","LU1046421795.USD","NVIW.SI",".IXIC","ESPR","LU0496365809.HKD","COCH","QID","BK4543","BK4168","LU1267930227.SGD","MNQmain","PSQ","PCOM","SEM","BK4122","LU0211326755.USD","BK4588","LU0310800965.SGD","BK4185","ZNB","CRML","NQmain","BK4515","BK4204","BK4007","LU1235294995.USD","LU1823568750.SGD","QLD","USAW.SI","LU0128525689.USD","SQQQ","LU0267386448.USD","LU0211326839.USD"],"gpt_icon":1},{"id":"2573693924","title":"Nasdaq Gains 150 Points; US Mortgage Applications Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2573693924","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573693924?lang=en_us&edition=fundamental","pubTime":"2025-10-08 22:22","pubTimestamp":1759933355,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/10/48101541/nasdaq-gains-150-points-us-mortgage-applications-decline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","PSQ","BK4139","BK4190","BK4122","QLD",".IXIC","BK4082","NQmain","YYAI","PCOM","XBIO","COCH","SQQQ","BK4204","USAW.SI","ATON","ZNB","MNQmain","QID","TSYW.SI","TQQQ","NVIW.SI"],"gpt_icon":1},{"id":"2573928633","title":"Envoy Medical Signs Deals for Sale of Common Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928633","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928633?lang=en_us&edition=fundamental","pubTime":"2025-10-08 19:57","pubTimestamp":1759924668,"startTime":"0","endTime":"0","summary":"Envoy Medical  said Wednesday it has entered into deals for the sale of more than 3 million Class A common shares at $1.33 apiece through a registered direct offering.The company will also sell unregistered warrants to buy up to roughly 9 million Class A shares that are immediately exercisable at $1.33 per share over a 24-month period, Envoy Medical said.Full exercise of the warrants will likely raise about $12 million, the company added.Envoy Medical also said it expects to close the offering around Thursday, with net proceeds due to be allocated toward working capital and other general corporate purposes.The company's shares were down more than 32% in recent Wednesday premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2573479249","title":"Envoy Medical Announces $16 Million Registered Direct and Private Placement Offering, Including $4 Million Upfront and Warrants for Potential $12 Million Additional Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2573479249","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573479249?lang=en_us&edition=fundamental","pubTime":"2025-10-08 19:01","pubTimestamp":1759921262,"startTime":"0","endTime":"0","summary":"Envoy Medical Announces $16 Million Registered Direct and Private Placement Offering, Including $4 Million Upfront and Warrants for Potential $12 Million Additional Proceeds. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile  on October 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL5HfV0s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2573968669","title":"Envoy Medical Inc. Announces Date for Upcoming Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2573968669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573968669?lang=en_us&edition=fundamental","pubTime":"2025-10-08 04:58","pubTimestamp":1759870715,"startTime":"0","endTime":"0","summary":"Envoy Medical Inc. has announced that it will hold a Special Meeting of Stockholders on November 26, 2025, at its location in White Bear Lake, Minnesota. During the meeting, stockholders will be asked to vote on the approval of the issuance of warrants to purchase shares of the company's Class A Common Stock. Additionally, a proposal to approve one or more adjournments of the meeting, if necessary, will also be considered. Other business matters that may properly come before the meeting or any adjournments thereof may also be addressed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDLbm1MVd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2573458969","title":"BRIEF-Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2573458969","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573458969?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:39","pubTimestamp":1759851586,"startTime":"0","endTime":"0","summary":"BRIEF-Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final StageOct 7  - Envoy Medical Inc COCH.O:ENVOY MEDICAL: RECEIVES FDA APPROVAL TO ADVANCE ITS PIVOTAL CLINICAL TRIAL TO FINAL STAGE BASED ON SUBMISSION OF PROMISING THREE-MONTH DATAENVOY MEDICAL INC - EXPECTS FULL ENROLLMENT BY EARLY 2026 - SEC FILINGENVOY MEDICAL INC -MOVING ITS TIMELINES UP THREE TO SIX MONTHS, CUTTING ITS ANTICIPATED CAPITAL NEED BY $10-$15 MILLIONSource text: [ID:n0001213900-25-096845]Further company coverage: COCH.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO02M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCH","BK4082"],"gpt_icon":0},{"id":"2573963069","title":"Envoy Medical: Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2573963069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573963069?lang=en_us&edition=fundamental","pubTime":"2025-10-07 22:05","pubTimestamp":1759845935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO02M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2573630979","title":"Envoy Medical Inc -Moving Its Timelines up Three to Six Months, Cutting Its Anticipated Capital Need by $10-$15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2573630979","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573630979?lang=en_us&edition=fundamental","pubTime":"2025-10-07 22:05","pubTimestamp":1759845935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO02M:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","COCH"],"gpt_icon":0},{"id":"2573061963","title":"Envoy Medical Inc - Expects Full Enrollment by Early 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2573061963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573061963?lang=en_us&edition=fundamental","pubTime":"2025-10-07 22:05","pubTimestamp":1759845935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO02M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCH","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}